Trial | Hand grip strength (N) | |||
---|---|---|---|---|
VR | VL | HR | HL | |
Pre-experimental trial (7 days before RIF) | ||||
CG | 301.55±37.36 | 309.40±47.66 | 304.30±36.58 | 304±42.07 |
EG | 294.49±55.02 | 30.68±64.14 | 291.06±53.74 | 300.87±48.84 |
1st experimental trial (1st day) | ||||
CG | 309.69±38.34 | 314.11±46.48 | 306.26±43.74 | 312.83±34..62 |
EG | 310.09±51.39 | 315.19±49.72 | 309.30±51.29 | 313.81±41.38 |
2nd experimental trial (8th day) | ||||
CG | 308.22±43.93 | 315.09±42.17 | 310.18±42.86 | 312.63±38.25 |
EG | 296.85±51.78 | 309±55.02 | 303.22±45.01 | 308.03±52.47 |
3rd experimental trial (16th day) | ||||
CG | 311.36±43.64 | 319.70±45.70 | 309.40±44.62 | 313.62±36.68 |
EG | 299.79±57.27 | 307.14±56.88 | 299.79±55.60 | 299.99±51.78 |
4th experimental trial (22nd day) | ||||
CG | 302.54±43.25 | 311.36±50.21 | 298.42±46.09 | 307.73±41.48 |
EG | 297.93±52.37 | 310.09±59.04 | 303.22±58.45 | 301.36±50.41 |
5th experimental trial (30th day) | ||||
CG | 302.54±41.48 | 311.46±49.62 | 295.67±41.19 | 306.75±45.40 |
EG | 296.55±51.58 | 305.38±54.82 | 304.50±55.80 | 299.79±55.88 |
Postexperimental trial (15 days after RIF) | ||||
CG | 301.06±40.70 | 312.64±41.38 | 290.57±45.52 | 304.99±40.60 |
EG | 295.77±50.11 | 292.83±53.54 | 284.88±50.70 | 293.12±48.35 |
One way repeated measure ANOVA showed no significant difference.
ANOVA, analysis of variance; CG, control group (n=40); EG, experimental group (n=37); HL, horizontal left; HR, horizontal right; VL, vertical left; VR, vertical right; RIF, Ramadam intermittent fasting.